drugset / Trial / NCT01270256
NasoNeb Delivery of an Intranasal Steroid
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to see if a nasal steroid drug delivered to the nose with the NasoNeb™ inhaler improves the symptoms of people with perennial allergic rhinitis (year round allergy symptoms).
Timeline
- Start
- 2011-01
- Primary completion
- 2012-07
- Completion
- 2012-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Budesonide | Small molecule | 0.25 mg | Intranasal |